Tectonic raises $185M via PIPE of 3.69M shares to fund clinical pipeline

Tectonic Therapeutic, Inc.

Gross proceeds ~$185M; 3,689,465 shares at $50.00 (fund investors) and $54.14 (officer/directors).
Expected close Feb 5, 2025; net proceeds for TX45, TX2100, discovery platform, and working capital.
New and existing investors include Adage Capital, Ally Bridge, Deep Track, EcoR1, Farallon, and others.
TD Cowen, Leerink, Piper Sandler, Wells Fargo acted as placement agents; resale registration to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.